Cancer-induced immunosuppressive cascades and their reversal by molecular-targeted therapy

Yutaka Kawakami, Tomonori Yaguchi, Hidetoshi Sumimoto, Chie Kudo-Saito, Nobuo Tsukamoto, Tomoko Iwata-Kajihara, Shoko Nakamura, Hiroshi Nishio, Ryosuke Satomi, Asuka Kobayashi, Mayuri Tanaka, Jeong Hoon Park, Hajime Kamijuku, Takahiro Tsujikawa, Naoshi Kawamura

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Immunological status in tumor tissues varies among patients. Infiltration of memory-type CD8+ T cells into tumors correlates with prognosis of patients with various cancers. However, the mechanism of the differential CD8+ T cell infiltration has not been well investigated. In general, tumor-associated microenvironments, including tumor and sentinel lymph nodes, are under immunosuppressive conditions such that the immune system is not able to eliminate cancer cells without immune-activating interventions. Constitutive activation of various signaling pathways in human cancer cells triggers multiple immunosuppressive cascades that involve various cytokines, chemokines, and immunosuppressive cells. Signaling pathway inhibitors could inhibit these immunosuppressive cascades by acting on either cancer or immune cells, or both. In addition, common signaling mechanisms are often utilized for multiple hallmarks of cancer (e.g., cell proliferation/survival, invasion/metastasis, and immunosuppression). Therefore, targeting these common signaling pathways may be an attractive strategy for cancer therapy including immunotherapy.

Original languageEnglish
Pages (from-to)80-86
Number of pages7
JournalAnnals of the New York Academy of Sciences
Volume1284
Issue number1
DOIs
Publication statusPublished - 2013 May

Fingerprint

Molecular Targeted Therapy
Immunosuppressive Agents
Tumors
T-cells
Infiltration
Neoplasms
Cells
Immune system
Cell proliferation
Chemokines
Chemical activation
Tissue
Cytokines
Data storage equipment
T-Lymphocytes
Therapy
Cancer
Tumor Microenvironment
Immunotherapy
Immunosuppression

Keywords

  • β-catenin
  • BRAF
  • Immunosuppression
  • NF-κB
  • STAT3

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • History and Philosophy of Science

Cite this

Cancer-induced immunosuppressive cascades and their reversal by molecular-targeted therapy. / Kawakami, Yutaka; Yaguchi, Tomonori; Sumimoto, Hidetoshi; Kudo-Saito, Chie; Tsukamoto, Nobuo; Iwata-Kajihara, Tomoko; Nakamura, Shoko; Nishio, Hiroshi; Satomi, Ryosuke; Kobayashi, Asuka; Tanaka, Mayuri; Park, Jeong Hoon; Kamijuku, Hajime; Tsujikawa, Takahiro; Kawamura, Naoshi.

In: Annals of the New York Academy of Sciences, Vol. 1284, No. 1, 05.2013, p. 80-86.

Research output: Contribution to journalArticle

Kawakami, Y, Yaguchi, T, Sumimoto, H, Kudo-Saito, C, Tsukamoto, N, Iwata-Kajihara, T, Nakamura, S, Nishio, H, Satomi, R, Kobayashi, A, Tanaka, M, Park, JH, Kamijuku, H, Tsujikawa, T & Kawamura, N 2013, 'Cancer-induced immunosuppressive cascades and their reversal by molecular-targeted therapy', Annals of the New York Academy of Sciences, vol. 1284, no. 1, pp. 80-86. https://doi.org/10.1111/nyas.12094
Kawakami, Yutaka ; Yaguchi, Tomonori ; Sumimoto, Hidetoshi ; Kudo-Saito, Chie ; Tsukamoto, Nobuo ; Iwata-Kajihara, Tomoko ; Nakamura, Shoko ; Nishio, Hiroshi ; Satomi, Ryosuke ; Kobayashi, Asuka ; Tanaka, Mayuri ; Park, Jeong Hoon ; Kamijuku, Hajime ; Tsujikawa, Takahiro ; Kawamura, Naoshi. / Cancer-induced immunosuppressive cascades and their reversal by molecular-targeted therapy. In: Annals of the New York Academy of Sciences. 2013 ; Vol. 1284, No. 1. pp. 80-86.
@article{6032859b3c1b439e9d99f9aba8d88344,
title = "Cancer-induced immunosuppressive cascades and their reversal by molecular-targeted therapy",
abstract = "Immunological status in tumor tissues varies among patients. Infiltration of memory-type CD8+ T cells into tumors correlates with prognosis of patients with various cancers. However, the mechanism of the differential CD8+ T cell infiltration has not been well investigated. In general, tumor-associated microenvironments, including tumor and sentinel lymph nodes, are under immunosuppressive conditions such that the immune system is not able to eliminate cancer cells without immune-activating interventions. Constitutive activation of various signaling pathways in human cancer cells triggers multiple immunosuppressive cascades that involve various cytokines, chemokines, and immunosuppressive cells. Signaling pathway inhibitors could inhibit these immunosuppressive cascades by acting on either cancer or immune cells, or both. In addition, common signaling mechanisms are often utilized for multiple hallmarks of cancer (e.g., cell proliferation/survival, invasion/metastasis, and immunosuppression). Therefore, targeting these common signaling pathways may be an attractive strategy for cancer therapy including immunotherapy.",
keywords = "β-catenin, BRAF, Immunosuppression, NF-κB, STAT3",
author = "Yutaka Kawakami and Tomonori Yaguchi and Hidetoshi Sumimoto and Chie Kudo-Saito and Nobuo Tsukamoto and Tomoko Iwata-Kajihara and Shoko Nakamura and Hiroshi Nishio and Ryosuke Satomi and Asuka Kobayashi and Mayuri Tanaka and Park, {Jeong Hoon} and Hajime Kamijuku and Takahiro Tsujikawa and Naoshi Kawamura",
year = "2013",
month = "5",
doi = "10.1111/nyas.12094",
language = "English",
volume = "1284",
pages = "80--86",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Cancer-induced immunosuppressive cascades and their reversal by molecular-targeted therapy

AU - Kawakami, Yutaka

AU - Yaguchi, Tomonori

AU - Sumimoto, Hidetoshi

AU - Kudo-Saito, Chie

AU - Tsukamoto, Nobuo

AU - Iwata-Kajihara, Tomoko

AU - Nakamura, Shoko

AU - Nishio, Hiroshi

AU - Satomi, Ryosuke

AU - Kobayashi, Asuka

AU - Tanaka, Mayuri

AU - Park, Jeong Hoon

AU - Kamijuku, Hajime

AU - Tsujikawa, Takahiro

AU - Kawamura, Naoshi

PY - 2013/5

Y1 - 2013/5

N2 - Immunological status in tumor tissues varies among patients. Infiltration of memory-type CD8+ T cells into tumors correlates with prognosis of patients with various cancers. However, the mechanism of the differential CD8+ T cell infiltration has not been well investigated. In general, tumor-associated microenvironments, including tumor and sentinel lymph nodes, are under immunosuppressive conditions such that the immune system is not able to eliminate cancer cells without immune-activating interventions. Constitutive activation of various signaling pathways in human cancer cells triggers multiple immunosuppressive cascades that involve various cytokines, chemokines, and immunosuppressive cells. Signaling pathway inhibitors could inhibit these immunosuppressive cascades by acting on either cancer or immune cells, or both. In addition, common signaling mechanisms are often utilized for multiple hallmarks of cancer (e.g., cell proliferation/survival, invasion/metastasis, and immunosuppression). Therefore, targeting these common signaling pathways may be an attractive strategy for cancer therapy including immunotherapy.

AB - Immunological status in tumor tissues varies among patients. Infiltration of memory-type CD8+ T cells into tumors correlates with prognosis of patients with various cancers. However, the mechanism of the differential CD8+ T cell infiltration has not been well investigated. In general, tumor-associated microenvironments, including tumor and sentinel lymph nodes, are under immunosuppressive conditions such that the immune system is not able to eliminate cancer cells without immune-activating interventions. Constitutive activation of various signaling pathways in human cancer cells triggers multiple immunosuppressive cascades that involve various cytokines, chemokines, and immunosuppressive cells. Signaling pathway inhibitors could inhibit these immunosuppressive cascades by acting on either cancer or immune cells, or both. In addition, common signaling mechanisms are often utilized for multiple hallmarks of cancer (e.g., cell proliferation/survival, invasion/metastasis, and immunosuppression). Therefore, targeting these common signaling pathways may be an attractive strategy for cancer therapy including immunotherapy.

KW - β-catenin

KW - BRAF

KW - Immunosuppression

KW - NF-κB

KW - STAT3

UR - http://www.scopus.com/inward/record.url?scp=84877331674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877331674&partnerID=8YFLogxK

U2 - 10.1111/nyas.12094

DO - 10.1111/nyas.12094

M3 - Article

C2 - 23651199

AN - SCOPUS:84877331674

VL - 1284

SP - 80

EP - 86

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

IS - 1

ER -